MPLT
NASDAQ · Biotechnology
Maplight Therapeutics Inc
$17.80
+0.82 (+4.83%)
Open$16.77
Previous Close$16.98
Day High$17.94
Day Low$16.77
52W High$21.55
52W Low$12.24
Volume—
Avg Volume145.9K
Market Cap823.97M
P/E Ratio—
EPS$-1.87
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+255.0% upside
Current
$17.80
$17.80
Target
$63.19
$63.19
$44.21
$63.19 avg
$83.67
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 110.57M | 109.60M | 110.00M |
| Net Income | -5,057,192 | -4,807,023 | -6,303,306 |
| Profit Margin | -4.6% | -4.4% | -5.7% |
| EBITDA | -7,551,548 | -8,325,034 | -7,754,101 |
| Free Cash Flow | -7,533,825 | -4,832,804 | -6,604,673 |
| Rev Growth | +23.3% | +7.4% | -2.1% |
| Debt/Equity | 0.30 | 0.38 | 0.35 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $207.18 | +0.96% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.93 | +1.58% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.26 | +0.11% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $454.97 | +1.42% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $749.47 | +1.05% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.70 | +6.70% | 139.7 | 43.84B |